Similar articles

• Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.

  Jaskłowska-Englisz M, Olszewski WL, Maksymowicz M, Ziółkowska A. Jaskłowska-Englisz M, et al. Ann Transplant. 1998;3(1):28-33. Ann Transplant. 1998. PMID: 9869895
• Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected.

  Jaskłowska-Englisz M, Olszewski WL. Jaskłowska-Englisz M, et al. Transplant Proc. 1994 Dec;26(6):3463. Transplant Proc. 1994. PMID: 7998224 No abstract available.
• Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.

  Schmidbauer G, Hancock WW, Wasowska BA, Sablinski T, Kupiec-Weglinski JW. Schmidbauer G, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):712-3. Transplant Proc. 1993. PMID: 8438450 No abstract available.
• In vitro correlates of rejection. III. Immunologic models for the study of a variety of kidney and heart transplant rejection and prolongation phenomena.

  Guttmann RD. Guttmann RD. Transplant Proc. 1978 Jun;10(2):361-6. Transplant Proc. 1978. PMID: 79258 Review. No abstract available.
• Role of heat shock protein immunity in allograft rejection.

  Duquesnoy RJ, Moliterno R, Qian J, Donovan-Peluso M, Pan F, Valdivia L. Duquesnoy RJ, et al. Transplant Proc. 1995 Feb;27(1):468-70. Transplant Proc. 1995. PMID: 7879065 Review. No abstract available.